Overview
Lung cancer is a malignancy arising from the epithelial cells of the airways and lung parenchyma, broadly divided into non-small-cell and small-cell types that differ in biology, growth pattern, and treatment. It develops through accumulated genetic damage, frequently linked to tobacco smoke and other inhaled carcinogens, and is clinically significant because it often presents at an advanced stage and can metastasize to sites such as the adrenal glands, bone, and brain. Management combines surgery, radiotherapy, cytotoxic chemotherapy, targeted agents, and immunotherapy, with treatment selection guided by histology, stage, and molecular features. Research in this area examines the roles of host and pharmacological factors in disease course, including investigations of statins and of heparin in lung cancer, as well as evolving surgical practice and the impact of immunotherapy on the extent of pulmonary resection. Allied work addresses tumor cell biology in experimental systems, biomarker development on advanced disease-modeling platforms, and the nutritional management of cancer-associated cachexia. Complementary preventive strategies are also considered. Collectively, scholarship on lung cancer seeks earlier detection, more precise classification, and better-tolerated, more effective treatment, while clarifying the cellular and systemic mechanisms that drive progression and resistance.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Statins and Lung Cancer: A Review of Current Literature
The Role of Heparin in Lung Cancer
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
Challenger and Propose Novel Methods and Techniques for Prevention, Prognosis, Diagnosis, Imaging, Screening, Treatment and Management of Lung Cancer
High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development
Evolution of the Solid Human Tumor Cells Properties in Various Experimental Systems in Vitro
Thyroid Transcription Factor-1 Activity is Required for the Proliferation of Human Thyroid Cancer Cells 8505C
Immunotherapy Usage Has Not Increased Sub-Lobar Pulmonary Resections Despite Reduced Pneumonectomies
Overexpression of Prostate Apoptosis Response Protein-4 In Colon Cancer Cells Can Inhibit Metastasis by Upregulating E-cadherin Expression
Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
How this research is being cited
The 12 articles above have been cited 22 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Discover Oncology
-
2025 · Discover Oncology
-
2023 · Siberian Journal of Oncology
-
2023 · Siberian journal of oncology
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
2022 · Effective Pharmacotherapy
-
2022 · Cancers
-
2022 · Cancers
A sample of recent works citing this journal's research on Lung Cancer, linking to each citing work.